TRENDS IN PHARMACOLOGICAL SCIENCES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1098419, encodeId=3c09109841947, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226304, encodeId=0ff612263042d, content=请问可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Tue Jun 14 01:02:08 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098420, encodeId=dbe11098420bc, content=researcharticle和其它文章类型有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546367, encodeId=f04454636eb3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：只接受邀请，也可以询问可否投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5db72141743, createdName=千里逐梦, createdTime=Tue Sep 05 23:10:00 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506191, encodeId=3d2350619143, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：杂志基本都是约稿，但也欢迎毛遂自荐，被编辑同意后，也按约稿投稿，感觉一旦同意投稿了，就相对容易中了，编辑很nice，审稿意见返回后，编辑还会帮忙修改整篇稿件，然后把修改后的稿件连同审稿意见一同发给你，很是贴心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Sep 21 22:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=)]

2021-12-27 Mia

什么是Protocol？

54 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1098419, encodeId=3c09109841947, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226304, encodeId=0ff612263042d, content=请问可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Tue Jun 14 01:02:08 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098420, encodeId=dbe11098420bc, content=researcharticle和其它文章类型有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546367, encodeId=f04454636eb3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：只接受邀请，也可以询问可否投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5db72141743, createdName=千里逐梦, createdTime=Tue Sep 05 23:10:00 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506191, encodeId=3d2350619143, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：杂志基本都是约稿，但也欢迎毛遂自荐，被编辑同意后，也按约稿投稿，感觉一旦同意投稿了，就相对容易中了，编辑很nice，审稿意见返回后，编辑还会帮忙修改整篇稿件，然后把修改后的稿件连同审稿意见一同发给你，很是贴心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Sep 21 22:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=)]

2022-06-14 ms5000000640975514

请问可以共一吗？

42 0

[GetPortalCommentsPageByObjectIdResponse(id=1098419, encodeId=3c09109841947, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226304, encodeId=0ff612263042d, content=请问可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Tue Jun 14 01:02:08 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098420, encodeId=dbe11098420bc, content=researcharticle和其它文章类型有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546367, encodeId=f04454636eb3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：只接受邀请，也可以询问可否投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5db72141743, createdName=千里逐梦, createdTime=Tue Sep 05 23:10:00 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506191, encodeId=3d2350619143, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：杂志基本都是约稿，但也欢迎毛遂自荐，被编辑同意后，也按约稿投稿，感觉一旦同意投稿了，就相对容易中了，编辑很nice，审稿意见返回后，编辑还会帮忙修改整篇稿件，然后把修改后的稿件连同审稿意见一同发给你，很是贴心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Sep 21 22:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=)]

2021-12-27 学医的彭于晏

researcharticle和其它文章类型有什么区别？

49 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1098419, encodeId=3c09109841947, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226304, encodeId=0ff612263042d, content=请问可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Tue Jun 14 01:02:08 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098420, encodeId=dbe11098420bc, content=researcharticle和其它文章类型有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546367, encodeId=f04454636eb3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：只接受邀请，也可以询问可否投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5db72141743, createdName=千里逐梦, createdTime=Tue Sep 05 23:10:00 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506191, encodeId=3d2350619143, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：杂志基本都是约稿，但也欢迎毛遂自荐，被编辑同意后，也按约稿投稿，感觉一旦同意投稿了，就相对容易中了，编辑很nice，审稿意见返回后，编辑还会帮忙修改整篇稿件，然后把修改后的稿件连同审稿意见一同发给你，很是贴心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Sep 21 22:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=)]

2017-09-05 千里逐梦

审稿速度:2.0 | 投稿命中率:25.0
经验分享：只接受邀请，也可以询问可否投稿。

308 0

[GetPortalCommentsPageByObjectIdResponse(id=1098419, encodeId=3c09109841947, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226304, encodeId=0ff612263042d, content=请问可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Tue Jun 14 01:02:08 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098420, encodeId=dbe11098420bc, content=researcharticle和其它文章类型有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546367, encodeId=f04454636eb3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：只接受邀请，也可以询问可否投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5db72141743, createdName=千里逐梦, createdTime=Tue Sep 05 23:10:00 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506191, encodeId=3d2350619143, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：杂志基本都是约稿，但也欢迎毛遂自荐，被编辑同意后，也按约稿投稿，感觉一旦同意投稿了，就相对容易中了，编辑很nice，审稿意见返回后，编辑还会帮忙修改整篇稿件，然后把修改后的稿件连同审稿意见一同发给你，很是贴心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Sep 21 22:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=)]

2014-09-21 匿名用户

审稿速度:2.0 | 投稿命中率:25.0
经验分享：杂志基本都是约稿，但也欢迎毛遂自荐，被编辑同意后，也按约稿投稿，感觉一旦同意投稿了，就相对容易中了，编辑很nice，审稿意见返回后，编辑还会帮忙修改整篇稿件，然后把修改后的稿件连同审稿意见一同发给你，很是贴心。

403 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务